Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Akoya Biosciences and NeraCare Forge Exclusive Global License Agreement for Immunoprint Test Development in Melanoma Care

Akoya Biosciences and NeraCare announced a global license agreement to develop the Immunoprint test for early-stage melanoma.Quiver AI SummaryAkoya Biosciences, Inc. and NeraCare have entered into an exclusive...

AKYA : 2.49 (-2.35%)
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

AKYA : 2.49 (-2.35%)
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

AKYA : 2.49 (-2.35%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

/CNW/ -- USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among people under...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
RCUS : 15.50 (+0.26%)
BCTX : 0.5610 (-4.12%)
ONC.TO : 1.19 (-9.16%)
AKYA : 2.49 (-2.35%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
RCUS : 15.50 (+0.26%)
BCTX : 0.5610 (-4.12%)
AKYA : 2.49 (-2.35%)
ONC.TO : 1.19 (-9.16%)
Akoya: Q3 Earnings Snapshot

Akoya: Q3 Earnings Snapshot

AKYA : 2.49 (-2.35%)
Akoya Biosciences Reports Third Quarter 2024 Financial Results

AKYA : 2.49 (-2.35%)
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCodeâ„¢ Discovery IO60 and Mouse FFPE IO Panel

AKYA : 2.49 (-2.35%)
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

AKYA : 2.49 (-2.35%)
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

AKYA : 2.49 (-2.35%)

Barchart Exclusives

Stocks Set to Open Higher as Investors Recalibrate Fed Rate Cut Bets, U.S. Economic Data in Focus
March S&P 500 E-Mini futures (ESH25) are up +0.16%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.28% this morning, extending Friday’s solid gains after muted U.S. inflation data helped reignite Federal Reserve rate cut bets, while investors also awaited a fresh batch of U.S. economic data this week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar